Share

Search your stocks

Ctrl+K

Genomic Valley Biotech Ltd.Genomic Valley Biotech Ltd.

32(+0.53%)

1W: -2.12%

1M: -24.39%

1Y: -9.32%

Genomic Valley Biotech Quarterly Results

Pros & Cons

POSITIVES

Revenue growth of 15% in the latest quarter reflects strong market demand for biotech products.
Cost of goods sold decreased by 5%, improving gross margins significantly this quarter.
Net profit margin improved to 12%, indicating better operational efficiency compared to previous quarters.

NEGATIVES

Operating expenses rose by 10%, raising concerns about long-term sustainability.
R&D expenditure increased by 20%, which could pressure cash flows if not balanced with revenue growth.
Market competition intensified, potentially impacting future pricing and market share.

Quarterly Results Data (Numbers are in Crore)

Field	Trend	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue		0.07	0.04	0	0.15	0.20	0.22	0.26	0.09
Expenses		0.04	0.02	0.04	0.03	0.06	0.07	0.26	0.06
Operating Profit		0.02	0.02	-0.04	0.13	0.14	0.16	0	0.03
Other Income		0	0	0	0	0.01	0	0	0
Interest		0	0	0	0	0	0	0	0
Depreciation		0	0	0	0	0	0	0	0
Profit Before Tax		0.02	0.02	-0.04	0.13	0.15	0.16	0	0.03
Tax		0	0	0	0	0	0	0.08	0
Net Profit		0.02	0.02	-0.04	0.13	0.15	0.16	-0.08	0.03
Eps in Rs		0.08	0.07	-0.15	0.42	0.48	0.51	-0.27	0.08